{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T23:06:32Z","timestamp":1574377592864},"reference-count":11,"publisher":"Wiley","issue":"3","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1660,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1742-1241.2010.02594.x","type":"article-journal","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T12:29:33Z","timestamp":1297686573000},"page":"373-374","source":"Crossref","is-referenced-by-count":7,"title":"Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas","prefix":"10.1111","volume":"65","author":[{"given":"S. A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"J.","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"C.","family":"Zavos","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,2,14]]},"reference":[{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1742-1241.2009.02327.x","article-title":"Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease","volume":"64","author":"Kaser","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1872-034X.2010.00632.x","article-title":"Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis","volume":"40","author":"Polyzos","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"72","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1463-1326.2009.01176.x","article-title":"The role of adiponectin in the pathogenesis and treatment of nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB5|cit5","author":"Polyzos","year":"2010","article-title":"Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis","journal-title":"Metabolism","DOI":"10.1016\/j.metabol.2010.09.003","doi-asserted-by":"crossref"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1872-034X.2009.00509.x","article-title":"Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization","volume":"39","author":"Fukushima","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2004.11.050","article-title":"Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor","volume":"17","author":"Narasimhan","year":"2005","journal-title":"Mol Cell"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biocel.2009.12.021","article-title":"Adiponectin-it\u2019s all about the modifications","volume":"42","author":"Simpson","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1210\/jc.2009-2286","article-title":"Hypoadiponectinemia-cause or consequence of human \u2018insulin resistance\u2019?","volume":"95","author":"Cook","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2010.02594.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.mehy.2009.12.028","article-title":"Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin","volume":"74","author":"Polyzos","year":"2010","journal-title":"Med Hypotheses"}],"container-title":"International Journal of Clinical Practice","original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2010.02594.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T19:44:47Z","timestamp":1497901487000},"score":1.0,"subtitle":["Letters"],"short-title":[],"issued":{"date-parts":[[2011,2,14]]},"references-count":11,"journal-issue":{"published-print":{"date-parts":[[2011,3]]},"issue":"3"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1742-1241.2010.02594.x","relation":{"cites":[]},"ISSN":["1368-5031"],"subject":["General Medicine"]}